Reduction of Hepatic Fat Content by Dulaglutide for the Treatment of Diabetes Mellitus: A Two‐Centre Open, Single‐Arm Trial
Reduction in liver fat content effectively improves pancreatic islet function secretion, particularly postprandial c-peptide secretion, especially in the first hour after a meal. This improvement leads to a decrease in glycated haemoglobin levels and promotes better compliance with blood glucose control.
Authors
- Chuanfeng Liu (ORCID: https://orcid.org/0000-0002-6549-2013)
- Ruizhi Zhou (ORCID: https://orcid.org/0000-0003-3913-8640)
- Lili Xu (ORCID: https://orcid.org/0000-0001-6724-6257)
- Wei Wang (ORCID: https://orcid.org/0000-0001-5099-5171)
- Xin Yu (ORCID: https://orcid.org/0000-0001-9768-0695)
- Yangang Wang (ORCID: https://orcid.org/0000-0001-6597-420X)
- Yajing Huang (ORCID: https://orcid.org/0000-0002-3447-7689)
Institutions
- Qingdao University (CN)
- Jiaozuo University (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1002/edm2.70021
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16